Press releases

• Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent's RapidFire/MS Screening for Pharmaceutical Drug Discovery
• Evotec reports continued strong revenue growth in Q1 2012
• Evotec AG and 4-Antibody AG form strategic collaboration to innovate antibody selection
• Evotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)
• Evotec grants exclusive rights on EVT 401 in China to Conba Pharmaceutical
• Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration
• Evotec publishes DDup 2 – neurodegenerative diseases
• Evotec FY 2011: Significant Growth and Focused Investments Drive Profitability and Innovation
• Evotec and IR Pharma Establish Drug Discovery Alliance in the Field of Respiratory
• Squeeze-out process for DeveloGen completed
• Evotec and Harvard University Expand Strategic Alliance into Kidney Disease
• Evotec Receives 4th Milestone Payment in 2011 as Part of its Discovery Alliance with Boehringer Ingelheim
• Nine months results: Upside materialising
• Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi achieved
• Evotec and APEIRON Biologics start next project on the Cbl-b target
• Second multi-target collaboration with UCB announced
• Acquisition of remaining 30% of Indian Joint Venture from DIL
• Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
• Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim received
• Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
• Archive